SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-061732
Filing Date
2018-11-27
Accepted
2018-11-27 16:31:34
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506170_10q.htm 10-Q 568668
2 EXHIBIT 10.39 tv506170_ex10-39.htm EX-10.39 20423
3 EXHIBIT 10.40 tv506170_ex10-40.htm EX-10.40 20502
4 EXHIBIT 31.1 tv506170_ex31-1.htm EX-31.1 9739
5 EXHIBIT 31.2 tv506170_ex31-2.htm EX-31.2 9568
6 EXHIBIT 32.1 tv506170_ex32-1.htm EX-32.1 4933
  Complete submission text file 0001144204-18-061732.txt   6624555

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20180930.xml EX-101.INS 1959855
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20180930.xsd EX-101.SCH 49335
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20180930_cal.xml EX-101.CAL 40590
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20180930_def.xml EX-101.DEF 312036
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20180930_lab.xml EX-101.LAB 350482
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20180930_pre.xml EX-101.PRE 352407
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 181203364
SIC: 2834 Pharmaceutical Preparations